Kaiser, Kathrin
Prystaz, Katja
Vikman, Anna
Haffner-Luntzer, Melanie
Bergdolt, Stephanie
Strauss, Gudrun
Waetzig, Georg H.
Rose-John, Stefan
Ignatius, Anita http://orcid.org/0000-0002-4782-1979
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (INST40/491-1)
Deutsche Forschungsgemeinschaft (CRC841, CRC877)
Article History
Received: 5 February 2018
Accepted: 19 February 2018
First Online: 1 March 2018
Compliance with ethical standards
:
: Prof. Dr. Stefan Rose-John is an inventor on patents describing the function of sgp130Fc. He is also a shareholder of the CONARIS Research Institute (Kiel, Germany), which is commercially developing sgp130Fc proteins as therapeutics for inflammatory diseases. Georg H. Waetzig is an inventor on patents describing the function of sgp130Fc and an employee of CONARIS Research Institute AG. All other authors have no financial conflicts of interest.
: All applicable international, national, and institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.